IDH has three isomerase forms (IDH1/2/3), of which IDH1 and IDH2 are important indicators of glioma molecular classification, which are of great significance for the diagnosis, individualized treatment, and prognosis of gliomas [37]. Here, IDH1 is linked to central nervous system cancer.